← Eichor
Study identifier: NCT04294368 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Targeted Fortification of Donor Breast Milk in Preterm Infants

Condition: Prematurity; Extreme · Failure to Thrive in Newborn · Growth Retardation  ·  Sponsor: Columbia University

PhaseNA
Planned participants50
Who can joinAll sexes, 1 Day to 21 Days
Healthy volunteersNo

About this study

This study is a randomized controlled trial comparing standard fortification of donor breast milk to targeted fortification of donor breast milk in preterm infants. The purpose of the study is to determine if there is a benefit to target fortifying donor breast milk in the preterm population. The investigators hypothesize that infants receiving targeted fortification of donor breast milk will have improved growth compared to infants receiving standard fortification of donor breast milk.

This description comes directly from the study's public registry record.

Talk to the study team

Marianne Garland, MD  ·  212 305 0952  ·  mg71@cumc.columbia.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Columbia University Medical Center/ New York - PresbyterianNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04294368